SYNB

📎 Investment Objective

The Putnam BioRevolution ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the Putnam BioRevolution Index, which is designed to provide exposure to companies that are leading the development of innovative biological technologies.

✨ Key Features

• Exposure to companies at the forefront of the biorevolution and innovative biological technologies
• Passive index-tracking strategy designed to replicate the performance of the Putnam BioRevolution Index
• Broad diversification across the biorevolution industry
• Low expense ratio of 0.00%

⚠️ Primary Risks

• Sector concentration risk, as the fund is focused on the biorevolution industry
• Volatility risk, as the biorevolution sector can be subject to significant price swings
• Regulatory risk, as the biorevolution industry is heavily influenced by government policies and regulations
• Liquidity risk, as some of the underlying holdings may have limited trading volume

👤 Best For

The Putnam BioRevolution ETF may be suitable for investors with a long-term investment horizon, a high-risk tolerance, and an interest in gaining exposure to the rapidly evolving biorevolution industry. This ETF may be particularly appealing to investors seeking to capitalize on the potential growth of innovative biological technologies.